LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
On October 22, 2018, the FDA sent Vanda a Warning Letter which was addressed to Defendant Polymeropoulos.
- On October 22, 2018, the FDA sent Vanda a Warning Letter which was addressed to Defendant Polymeropoulos.
- Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
- Faruqi & Faruqi, LLP also encourages anyone with information regarding Vanda's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
- The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ).